Active, Not Recruiting
Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma
NCT06056895
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +16 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States